Prevalence, Determinants of Positivity, and Clinical Utility of Cryptococcal Antigenemia in Cambodian HIV-Infected Patients
about
Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settingsIntegrating cryptococcal antigen screening and pre-emptive treatment into routine HIV carePreventing Cryptococcosis-Shifting the Paradigm in the Era of Highly Active Antiretroviral TherapyCost effectiveness of cryptococcal antigen screening as a strategy to prevent HIV-associated cryptococcal meningitis in South AfricaCost-effectiveness of primary prophylaxis of AIDS associated cryptococcosis in CambodiaTreatment of cryptococcosis in the setting of HIV coinfection.Pulmonary cryptococcosis in solid organ transplant recipients: clinical relevance of serum cryptococcal antigen.Major role for amphotericin B-flucytosine combination in severe cryptococcosis.Prevalence of cryptococcal infection among advanced HIV patients in Argentina using lateral flow immunoassay.Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa.Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.Altered balance between Th17 and Th1 cells at mucosal sites predicts AIDS progression in simian immunodeficiency virus-infected macaques.Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitionsAcute/subacute cerebral infarction (ASCI) in HIV-negative adults with cryptococcal meningoencephalitis (CM): a MRI-based follow-up study and a clinical comparison to HIV-negative CM adults without ASCI.High prevalence of Cryptococcal antigenemia among HIV-infected patients receiving antiretroviral therapy in Ethiopia.Prevalence of cryptococcal antigenemia and cost-effectiveness of a cryptococcal antigen screening program--Vietnam.Prevalence, correlates, and outcomes of cryptococcal antigen positivity among patients with AIDS, United States, 1986-2012.Universal screening of Tanzanian HIV-infected adult inpatients with the serum cryptococcal antigen to improve diagnosis and reduce mortality: an operational study.Cryptococcal Antigenemia in Immunocompromised Human Immunodeficiency Virus Patients in Rural Tanzania: A Preventable Cause of Early Mortality.Prevalence and factors associated with cryptococcal antigenemia among severely immunosuppressed HIV-infected adults in Uganda: a cross-sectional study.Screening for cryptococcal antigenemia in anti-retroviral naïve AIDS patients in benin city, Nigeria.Estimated Prevalence of Cryptococcus Antigenemia (CrAg) among HIV-Infected Adults with Advanced Immunosuppression in Namibia Justifies Routine Screening and Preemptive Treatment.Molecular diagnosis of invasive mycoses of the central nervous system.Cryptococcal Antigenemia in Nigerian Patients With Advanced Human Immunodeficiency Virus: Influence of Antiretroviral Therapy AdherenceOutcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy.New Insights into HIV/AIDS-Associated Cryptococcosis.Prevalence and outcomes of cryptococcal antigenemia in HIV-seropositive patients hospitalized for suspected tuberculosis in Uganda.Comparison of cryptococcal antigenemia between antiretroviral naïve and antiretroviral experienced HIV positive patients at two hospitals in Ethiopia.The impact of routine cryptococcal antigen screening on survival among HIV-infected individuals with advanced immunosuppression in KenyaAsymptomatic cryptococcemia in resource-limited settings.Central nervous system immune reconstitution inflammatory syndrome.Asymptomatic cryptococcal antigenemia is associated with mortality among HIV-positive patients in Indonesia.Treatment of cryptococcal meningitis in resource limited settingsGender specific differences in the immune response to infection.Cryptococcal antigen screening and preemptive therapy in patients initiating antiretroviral therapy in resource-limited settings: a proposed algorithm for clinical implementation.Advancing the Field: Evidence for New Management Strategies in Invasive Fungal InfectionsThe cryptococcal antigen lateral flow assay: A point-of-care diagnostic at an opportune time.Evaluation of screening and treatment of cryptococcal antigenaemia among HIV-infected persons in Soweto, South Africa.CrAg lateral flow assay for cryptococcosis.Utility of clinical assessment, imaging, and cryptococcal antigen titer to predict AIDS-related complicated forms of cryptococcal meningitis.
P2860
Q24600270-0999EE85-4D8A-4168-8D55-6EA394B9DC29Q24610933-C3232B10-54D5-4772-A001-66EA1E13BE3AQ26994750-46ED4EF6-2313-45AC-ADD4-3420BC39CB61Q28534733-7F135BF2-164F-4614-BD73-87CAE8AFCBE3Q28748511-6A0550B5-7109-423C-BD7C-02619AA3711BQ30366117-5B9BA877-2576-4B67-8D62-D426689C3A16Q30426015-86C7B4E9-BDF7-4874-A4EF-8402A41953C2Q33358131-39CFD2D3-BD26-4496-B062-A61095FA089CQ33803185-BAF96885-9F9F-4CBB-9FDC-DBD21382F516Q33871884-89462230-B551-45FA-AD56-B7C76F38E7FDQ34020746-A4AD38F1-5DF7-498C-812E-B1CD66FCF28CQ34382386-4F196BAC-3446-4851-B544-2528D66216DAQ34516548-DB8E3ABF-6E35-4026-B07E-A03004BBE5F7Q34569482-F75D14AF-6132-4A6A-8990-81814B332C6BQ34613471-C37CB951-C928-463A-BA89-4EFEF102E264Q34692926-6A65C832-5245-45FD-99DE-358214752AFFQ35171867-72C623FC-6A08-4DC5-AA61-CADB6D180113Q35396977-880D6615-005E-40F0-A41A-954427E04239Q35880502-4152F1D6-C72A-463E-A660-F4B63D94285DQ35907878-22B77AC2-DF89-4504-B068-8AF46F8EED3DQ36088621-53C9F448-8BB3-44BA-BE70-EC2E32B0C19EQ36167708-8359227E-F8F4-4065-9359-31718D5F1559Q36218994-1C1AE827-867E-48FC-A79F-180470AC53DCQ36900055-E756FB42-0D16-4EBA-B978-DF26DD97CCC2Q36996124-D04F07EB-44A2-4F7C-8263-638E3598E902Q37156556-7F3786B0-A998-49B8-A66B-6C6CBC7448D6Q37189693-2DA4924D-52BE-48E3-A162-513CD8E29EEEQ37215923-4761FB68-58D3-442C-8F86-20625B64A62EQ37259604-025BD59F-B6BC-41F3-A0C6-2349EC97B175Q37259640-0A746448-AB9A-40A4-BAD4-C95CDB6CCB77Q37442512-7675114F-2DCC-4970-AAB8-745313F8EA7CQ37530766-493DE282-7DF7-465C-BACA-D88064A78D76Q37545277-01C8EA70-035C-4F3E-B0E5-BB26870ACE95Q37858452-F832FAB3-1E51-467D-BABE-1335B35AA048Q38046791-E7322CC1-14E5-40C4-93BC-8994D828BEF5Q38082740-8E8CCDB9-C106-42E9-BE36-56C8ABB0B56EQ38328870-8CF8BE66-8CEE-4B12-98C1-81EC67747BA0Q39030373-5CED9883-4162-49B8-B72E-85A173A6103FQ41903839-DE65C270-FA5B-4D00-AB98-3C17490ED794Q42021692-0F2C2975-216E-4EEA-A385-3B0A2E5FFDBD
P2860
Prevalence, Determinants of Positivity, and Clinical Utility of Cryptococcal Antigenemia in Cambodian HIV-Infected Patients
description
article
@en
im August 2007 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2007
@uk
name
Prevalence, Determinants of Po ...... ambodian HIV-Infected Patients
@en
Prevalence, Determinants of Po ...... ambodian HIV-Infected Patients
@nl
type
label
Prevalence, Determinants of Po ...... ambodian HIV-Infected Patients
@en
Prevalence, Determinants of Po ...... ambodian HIV-Infected Patients
@nl
prefLabel
Prevalence, Determinants of Po ...... ambodian HIV-Infected Patients
@en
Prevalence, Determinants of Po ...... ambodian HIV-Infected Patients
@nl
P2093
P50
P1476
Prevalence, Determinants of Po ...... ambodian HIV-Infected Patients
@en
P2093
Borann Sar
ChanChhaya Ngeth
Didier Laureillard
Fran??oise Dromer
Hak Chanroeun
Jean-Philippe Dousset
Laurent Ferradini
Romain Micol
P304
P356
10.1097/QAI.0B013E31811ED32C
P407
P577
2007-08-01T00:00:00Z